Prescription Stimulant Misuse Affects About 1-in-4 Users

A new cross-sectional study published in JAMA Psychiatry found that approximately 25% of U.S. adults aged 18 to 64 who use prescription stimulants report misusing them. This misuse includes taking higher or more frequent doses than prescribed, using the medication without a prescription, or for non-medical reasons. The study found that misuse rates were about three times higher for prescription amphetamines (such as Adderall and Vyvanse) compared to methylphenidates (like Ritalin and Concerta). Notably, individuals taking amphetamines were more likely to misuse them, with nearly 1,800 out of 5,300 users reporting misuse, compared to 90 out of 680 methylphenidate users.

The findings underscore the need for healthcare providers to monitor patients closely for signs of misuse, especially among those prescribed amphetamines. Given the higher propensity for misuse associated with amphetamines, clinicians should consider this risk when prescribing and may need to implement stricter monitoring protocols. Additionally, the study suggests that public health initiatives should focus on educating patients about the risks of stimulant misuse and promoting adherence to prescribed regimens.